Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
International and national guidelines on chronic obstructive pulmonary disease (COPD) emphasise bronchodilators as first-line therapy. However, in considering them the ‘foundation’ of treatment, attention has shifted from the fact that COPD is fundamentally an inflammatory disease. The mainstay ough...
Main Authors: | Elvis M. Irusen, Thandeka Malange |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2020-12-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/5198 |
Similar Items
-
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
by: Tashkin DP, et al.
Published: (2018-08-01) -
The role of inhaled and/or nasal corticosteroids on the bronchodilator response
by: Ju Kyung Lee, et al.
Published: (2010-11-01) -
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
by: Hsieh MJ, et al.
Published: (2018-09-01) -
Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01) -
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)
by: James D. Chalmers, et al.
Published: (2018-04-01)